This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
High bloodpressure, also known as hypertension, is a common condition that affects millions of people worldwide. Understanding how high bloodpressure impacts your heart and learning to manage it can significantly reduce your risk of heart disease and improve your overall health. What Is High BloodPressure?
Research Highlights: The weight loss medication tirzepatide significantly lowered the systolic bloodpressure of nearly 500 adults who had obesity and took the medication for 36 weeks, or about eight months, in a subset of an international clinical.
Young adults who reported higher stress as adolescents were more likely to have high bloodpressure, obesity and other cardiometabolic risk factors as adults, finds new study.
Research Highlights: In an analysis of 18 randomized clinical trials, people with obesity and high bloodpressure who underwent bariatric (weight-loss) surgery were almost three times more likely to achieve bloodpressure remission, defined as.
Tirzepatide, a dual GLP-1/GIP agonist approved for diabetes and obesity, was associated with significant bloodpressure reductions in an analysis of the SURMOUNT-1 trial.
Research Highlights: Consistently high scores of perceived stress during adolescence through adulthood may contribute to worse cardiometabolic health including obesity in young adults. Researchers suggest the adoption of healthy coping strategies.
Bariatric surgery is more effective in controlling hypertension rates, or high bloodpressure, in people with obesity and uncontrolled high bloodpressure compared to bloodpressure medication alone, according to a new study.
Young adults who reported higher stress during their teenage years to adulthood were more likely to have high bloodpressure, obesity and other cardiometabolic risk factors than their peers who reported less stress, according to new research published in the Journal of the American Heart Association.
How these conditions are linked mechanistically remains unclear, especially two of these: obesity and elevated bloodpressure. Pharmacological prevention of lipid droplet formation reverses the suppression of NO production in cell culture and in vivo and blunts bloodpressure elevation in response to a high-fat diet.
This study aims to investigate the impact of weight loss after LSG on the left ventricular myocardial work (LVMW) in obese patients and explore the clinical value of the left ventricular pressure - strain loop (LV - PSL).MethodsThirty
The risk of hypertension increased with the presence of associated CV risk factors and comorbidities, particularly diabetes, obesity and the metabolic syndrome, and decreased with the intensity of physical activity. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 Regarding antihypertensive treatments, 6.1% two drugs, and 19.6%
Children and teenagers living with overweight or obesity are more likely to have high bloodpressure as adults (aged 50–64 years), suggesting the processes behind the condition could begin as early as childhood, suggests new research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May).
ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in risk factors including high bloodpressure and obesity, total costs related to.
Driven by an older, more diverse population, along with a significant increase in risk factors including high bloodpressure and obesity, total costs related to cardiovascular disease (CVD) conditions are likely to triple by 2050, according to recent projections. At least 6 in 10 U.S.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.
The five classic risk factors for cardiovascular disease are well knownsmoking, high bloodpressure, high cholesterol, diabetes, and underweight or overweight/obesity. All increase the likelihood of heart ailments down the road.
These findings may inform efforts to prevent excessive weight gain early in life, a risk factor for adult obesity and related conditions, such as heart disease, high bloodpressure and diabetes.
Background Treating obesity may be a pathway to prevent and control hypertension. In the SURMOUNT-1 trial in people with obesity or overweight with weight-related complications, 72-week tirzepatide treatment led to clinically meaningful body weight and bloodpressure reduction. mm Hg systolic and 4.2
Research Highlights: Heart disease, Type 2 diabetes, high bloodpressure and obesity were more common and linked to reduced access to healthy food among people who lived in neighborhoods previously subjected to structural racism-based policies that.
They are authorized for treating obesity. IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits. GLP-1 RAs have been used for diabetes and found to improve CV outcomes in diabetic and nondiabetic patients.
A projected rise in heart disease and stroke – along with several key risk factors, including high bloodpressure and obesity – is likely to triple related costs to $1.8 According to their projections, from 2020 to 2050, high bloodpressure is expected to rise from 51.2% to 61% of the U.S. population. population.
The associations between obesity and hypertension are widely known, but a new JACC study reveals that weight-reducing gastric bypass surgery has a significant and lasting impact on patients’ need for antihypertensives. The GATEWAY trial assigned 100 participants (76% women, 43.8 of them achieved BPs below 130/80 mm Hg (vs.
Following the Z-transformation of the independent variables, we evaluated the relationships between the four bloodpressure indices and NAFLD through multivariable logistic regression models. This finding was confirmed in populations without exercise habits, under 60 years of age, with normal bloodpressure, and in non-obese groups.
Background Worldwide obesity has a high prevalence, as well as carries a high risk of several chronic diseases, including hypertension. Studies of the association between obesity and ambulatory bloodpressure (BP) are scarce and most use only body mass index (BMI) as indicator of adiposity.
Prolonged sitting also leads to a bending of major arteries in our legs, leading to a blood flow pattern known as turbulent flow, blood pooling, impaired circulation, and endothelial dysfunction. They also had measures of body weight and circumferences and bloodpressure assessed at these time points. kilograms (7.7
Guidelines on hypertension (high bloodpressure) generally recommend measurement of bloodpressure in both arms in the initial visit. They also suggest that the arm with higher bloodpressure recording should be used to record bloodpressure in subsequent visits.
Circadian rhythms in bloodpressure and heart rate, among other functions, are crucial for cardiovascular health and preventing cardiovascular disease. This is supported by studies showing that ALAN exposure is associated with a range of conditions like cardiometabolic disease, obesity, and diabetes.
Cardiovascular disease (CVD) is a critical public health concern, with risk factors such as high bloodpressure, abnormal blood sugar levels, elevated cholesterol, and obesity beginning in childhood.
Statement Highlights: By age 18, many adolescents have already developed heart disease risk factors, such as high bloodpressure, obesity, high cholesterol or Type 2 diabetes, and a growing number of younger adults are experiencing adverse.
Background:Hypertensive disorders of pregnancy are associated with cardiovascular disease; however, patterns of bloodpressure (BP) recovery are understudied. Hypertension, Ahead of Print. Pregnancy BPs were obtained during prenatal visits; postpartum BPs were prospectively obtained through home monitoring.
It looks like we might be able to add prediabetes and hypertension to the growing list of conditions that Eli Lilly’s “weight loss drug” tirzepatide is able to treat, after new analysis of the SURMOUNT-1 trial showed significant reductions in bloodpressure and diabetes progression. mm Hg systolic and 4.2 of placebo-takers.
Inhibition of NOX2 with gp91ds-tat, both ex vivo and in vivo, mitigated the CINA-induced elevation in superoxide production and bloodpressure response. Moreover, CINA increased vascular NOX2 expression and superoxide production exclusively in male offspring.
Patients with no history of atherosclerotic CVD started on bloodpressure and/or lipid and/or glucose lowering treatments were identified retrospectively and interviewed at least 6 months after the initiation of medication. obese (body mass index≥30 kg/m 2 ) and 53.5% women; mean age 61.7±10.8 women; mean age 61.7±10.8
Results suggest a high prevalence of fatty liver in adults with chronic HCV, which was significantly associated with central obesity, elevated bloodpressure, and metabolic syndrome.
Causes and Risk Factors Several factors can increase the likelihood of developing AFib: High BloodPressure : Elevated bloodpressure can strain the heart, contributing to the onset of AFib. Obesity : Excess weight increases the risk of heart-related issues, including AFib.
Background:Impaired left atrial (LA) function is observed in obese patients, however, there is little information on when LA dysfunction begins to appear. To clarify this issue, we assessed LA volume and function in obese infants.Methods:Two-dimensional speckle-tracking echocardiography was performed in 96 infants aged 4 months.
BackgroundWe have previously reported that male mice exposed to maternal separation and early weaning (MSEW), a model of early life stress, show sympathetic activation and increased bloodpressure in response to a chronic high‐fat diet. After chronic treatment with enalapril (2.5 mg/kg
Fasting blood samples collected at the time of the cardiopulmonary exercise test were used to assay obesity-related biomarkers. Our findings suggest that among the obesity-related biomarkers studied, higher levels of leptin and CRP are independently associated with increased odds of HFpEF, with odds ratios of 1.36 (95% CI, 1.09–1.70)
Alterations in microcirculation play a crucial role in the pathogenesis of cardiovascular and metabolic disorders such as obesity and hypertension. In obesity, PVAT becomes enlarged and inflamed, and the bioavailability of adiponectin is reduced. The inevitable consequence is a rise in peripheral resistance with higher bloodpressure.
Background:Aldosterone regulates bloodpressure and electrolyte balance. Insulin signaling was assessed 15 minutes after stimulation with 17 nM insulin.Results:Esaxerenone improved insulin sensitivity (P<0.05) without altering metabolic parameters in HFD-induced obese and db/db mice.
There is a clear relationship between sleep deprivation and the development of conditions like obesity, diabetes, and hypertension. Bloodpressure increases : Both daytime and nighttime bloodpressure rise with sleep deprivation, particularly in women, heightening cardiovascular risk.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content